Steward Partners Investment Advisory, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 424 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$16,389
+34.3%
313
+4.3%
0.00%
Q1 2024$12,204
+10.1%
3000.0%0.00%
Q4 2023$11,088
-3.2%
3000.0%0.00%
Q3 2023$11,460
+5.9%
3000.0%0.00%
Q2 2023$10,821
-5.6%
3000.0%0.00%
Q1 2023$11,457
-84.5%
300
-76.9%
0.00%
-100.0%
Q4 2022$73,970
+45.0%
1,3000.0%0.00%0.0%
Q3 2022$51,000
-10.5%
1,3000.0%0.00%0.0%
Q2 2022$57,000
+307.1%
1,300
+271.4%
0.00%
Q3 2021$14,000
-12.5%
3500.0%0.00%
Q2 2021$16,000
-100.0%
350
-79.4%
0.00%
-100.0%
Q1 2021$70,874,000
+472393.3%
1,700
+385.7%
0.00%
Q4 2020$15,000
-64.3%
350
-85.4%
0.00%
-100.0%
Q4 2019$42,000
+13.5%
2,4000.0%0.00%0.0%
Q3 2019$37,000
-24.5%
2,400
-16.5%
0.00%
-50.0%
Q2 2019$49,000
-14.0%
2,875
-8.1%
0.00%
-33.3%
Q3 2018$57,000
+7.5%
3,130
-0.3%
0.00%0.0%
Q2 2018$53,0003,1400.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders